Joshua David Holt, FNP-C | |
1849 Madison St, Clarksville, TN 37043-5192 | |
(931) 802-6824 | |
(931) 802-6827 |
Full Name | Joshua David Holt |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 3 Years |
Location | 1849 Madison St, Clarksville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083361083 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 31241 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tennova Healthcare-clarksville | Clarksville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pain Institute Of Nashville Plc | 6103186689 | 5 |
News Archive
Umeå University honours Professor Emmanuelle Charpentier for her pioneering research with the powerful discovery of CRISPR-Cas9, which has already been of great importance by providing new opportunities for Life Science research and its applications in Biology and Medicine. Umeå University will present a special Jubilee Award to Emmanuelle Charpentier
The onset of the COVID-19 pandemic has brought about an international effort to uncover the biology of its causative agent, SARS-CoV-2, and to develop effective and safe antivirals to contain and treat the infection. A new study by a team of researchers in France and Sweden discusses one such study, exploring the relative immunogenicity of the three main structural proteins of the virus.
Pediatricians, economists, social scientists and policy experts will come together on Saturday, May 4, to address one of the greatest threats to child health - poverty.
Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia Pacific region, announced today an agreement for the exclusive distribution and promotion by Invida of Ipsen's drugs Diphereline® 3.75mg & 11.25mg, Somatuline® Autogel® and Increlex® in selected countries in South-East Asia.
› Verified 1 days ago
Entity Name | Pain Institute Of Nashville Plc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073049102 PECOS PAC ID: 6103186689 Enrollment ID: O20180131002665 |
News Archive
Umeå University honours Professor Emmanuelle Charpentier for her pioneering research with the powerful discovery of CRISPR-Cas9, which has already been of great importance by providing new opportunities for Life Science research and its applications in Biology and Medicine. Umeå University will present a special Jubilee Award to Emmanuelle Charpentier
The onset of the COVID-19 pandemic has brought about an international effort to uncover the biology of its causative agent, SARS-CoV-2, and to develop effective and safe antivirals to contain and treat the infection. A new study by a team of researchers in France and Sweden discusses one such study, exploring the relative immunogenicity of the three main structural proteins of the virus.
Pediatricians, economists, social scientists and policy experts will come together on Saturday, May 4, to address one of the greatest threats to child health - poverty.
Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia Pacific region, announced today an agreement for the exclusive distribution and promotion by Invida of Ipsen's drugs Diphereline® 3.75mg & 11.25mg, Somatuline® Autogel® and Increlex® in selected countries in South-East Asia.
› Verified 1 days ago
Entity Name | Montgomery Pain Institute Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891408191 PECOS PAC ID: 6800261868 Enrollment ID: O20230405002835 |
News Archive
Umeå University honours Professor Emmanuelle Charpentier for her pioneering research with the powerful discovery of CRISPR-Cas9, which has already been of great importance by providing new opportunities for Life Science research and its applications in Biology and Medicine. Umeå University will present a special Jubilee Award to Emmanuelle Charpentier
The onset of the COVID-19 pandemic has brought about an international effort to uncover the biology of its causative agent, SARS-CoV-2, and to develop effective and safe antivirals to contain and treat the infection. A new study by a team of researchers in France and Sweden discusses one such study, exploring the relative immunogenicity of the three main structural proteins of the virus.
Pediatricians, economists, social scientists and policy experts will come together on Saturday, May 4, to address one of the greatest threats to child health - poverty.
Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia Pacific region, announced today an agreement for the exclusive distribution and promotion by Invida of Ipsen's drugs Diphereline® 3.75mg & 11.25mg, Somatuline® Autogel® and Increlex® in selected countries in South-East Asia.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Joshua David Holt, FNP-C 1849 Madison St, Clarksville, TN 37043-5192 Ph: (931) 802-6824 | Joshua David Holt, FNP-C 1849 Madison St, Clarksville, TN 37043-5192 Ph: (931) 802-6824 |
News Archive
Umeå University honours Professor Emmanuelle Charpentier for her pioneering research with the powerful discovery of CRISPR-Cas9, which has already been of great importance by providing new opportunities for Life Science research and its applications in Biology and Medicine. Umeå University will present a special Jubilee Award to Emmanuelle Charpentier
The onset of the COVID-19 pandemic has brought about an international effort to uncover the biology of its causative agent, SARS-CoV-2, and to develop effective and safe antivirals to contain and treat the infection. A new study by a team of researchers in France and Sweden discusses one such study, exploring the relative immunogenicity of the three main structural proteins of the virus.
Pediatricians, economists, social scientists and policy experts will come together on Saturday, May 4, to address one of the greatest threats to child health - poverty.
Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia Pacific region, announced today an agreement for the exclusive distribution and promotion by Invida of Ipsen's drugs Diphereline® 3.75mg & 11.25mg, Somatuline® Autogel® and Increlex® in selected countries in South-East Asia.
› Verified 1 days ago
Amber L Schacht, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 881 Professional Park Dr, Clarksville, TN 37040 Phone: 931-645-4685 Fax: 931-245-2117 | |
Mrs. Brittney Wilkinson Lesser, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 647 Dunlop Ln Ste 301, Clarksville, TN 37040 Phone: 931-431-4677 | |
Katherine R Harrison, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 800 Weatherly, Suite 201, Clarksville, TN 37043 Phone: 931-648-1912 Fax: 931-648-1277 | |
Danielle Reine Schaaf, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 350 Pageant Ln Ste 307, Clarksville, TN 37040 Phone: 931-906-2001 | |
Willie Lance Lemusu, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 103 Jefferson St, Clarksville, TN 37040 Phone: 931-266-4999 | |
Jennifer A Nelson, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 111 Otis Smith Dr, Clarksville, TN 37043 Phone: 931-553-6666 Fax: 931-553-4006 | |
Kristina Reilly, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 236 Uffelman Dr, Clarksville, TN 37043 Phone: 931-647-6305 |